Latest Close
$2.90
News
TVRD
Tvardi Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to TVRD.
1y Change
-$11.80 (-80.27%)
Market Cap
$27,205,902.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
GlobeNewswire • Apr 2, 2026
Read articleTvardi: Q4 Earnings Snapshot
Associated Press • Mar 31, 2026
Read articleTvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
GlobeNewswire • Mar 31, 2026
Read articleTvardi Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire • Feb 12, 2026
Read articleWe're Keeping An Eye On Tvardi Therapeutics' (NASDAQ:TVRD) Cash Burn Rate
Simply Wall St. • Feb 7, 2026
Read article